66 related articles for article (PubMed ID: 3211954)
1. Role of ADP in platelet aggregation and fibrinogen binding induced by prostaglandin endoperoxides: studies in a patient with a selective defect of ADP-induced platelet aggregation.
Cattaneo M; Randi AM; Canciani MT; Lecchi A; Mannuci PM
Prog Clin Biol Res; 1988; 283():279-83. PubMed ID: 3211954
[No Abstract] [Full Text] [Related]
2. Platelet activation induced by a stable analogue of endoperoxides (U46619).
Zatta A; Prosdocimi M
Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
[No Abstract] [Full Text] [Related]
3. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets.
Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L
Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
[No Abstract] [Full Text] [Related]
5. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.
DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P
Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
8. How can we inhibit 5-HT-induced platelet aggregation and why should we bother?
Heptinstall S; Bevan J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):475-8. PubMed ID: 2465956
[TBL] [Abstract][Full Text] [Related]
9. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG
Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
[TBL] [Abstract][Full Text] [Related]
12. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
Altman R; Rouvier J; Weisenberger H
Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
[TBL] [Abstract][Full Text] [Related]
13. Desensitisation in human and rabbit blood platelets.
Hallam TJ; Ruggles PA; Scrutton MC; Wallis RB
Thromb Haemost; 1982 Jun; 47(3):278-84. PubMed ID: 7112500
[No Abstract] [Full Text] [Related]
14. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
di Minno G; Bertelé V; Bianchi L; Barbieri B; Cerletti C; Dejana E; de Gaetano G; Silver MJ
Thromb Haemost; 1981 Apr; 45(2):103-6. PubMed ID: 6266066
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
16. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
17. Comparison of GR32191, R68070 and CV-4151 upon U-46619- and collagen-induced platelet aggregation in vitro and ex vivo.
Watts IS; White BP; Wharton KA; Lumley P
Br J Pharmacol; 1989 Dec; 98 Suppl():842P. PubMed ID: 2611538
[No Abstract] [Full Text] [Related]
18. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain.
Zhou Q; Dangelmaier C; Smith JB
Biochem Biophys Res Commun; 1996 Feb; 219(3):720-6. PubMed ID: 8645248
[TBL] [Abstract][Full Text] [Related]
19. Succinate potentiates the action of platelet agonists.
Huang EM; McGowan EB; Detwiler TC
Thromb Res; 1984 Oct; 36(1):1-8. PubMed ID: 6095483
[TBL] [Abstract][Full Text] [Related]
20. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
